Anal Squamous Cell Carcinoma

19 clinical trials · Condition

Record	Firm	Date
Chemoradiotherapy Combined With or Without PD-1 Blockade in Anal Canal Squamous Carcinoma Patients (NCT05374252)	Sixth Affiliated Hospital, Sun Yat-sen University	2022-05-07
Re-optimization Based Online Adaptive Radiotherapy of Anal Cancer (NCT05438836)	Herlev Hospital	2022-01-01
PD-1 Blockade Combined With Chemotherapy Followed by Concurrent Immunoradiotherapy for Locally Advanced SCCA Patients (NCT05060471)	Sun Yat-sen University	2021-10-27
TiTAN-1: Safety, Proliferation and Persistence of GEN-011 Autologous Cell Therapy (NCT04596033)	Genocea Biosciences, Inc.	2020-11-11
4-Point Therapy Response Score With PET/CT for Anal Squamous Cell Cancer (NCT05130073)	M.D. Anderson Cancer Center	2019-07-31
Cisplatin and Fluorouracil Compared With Carboplatin and Paclitaxel in Treating Patients With Inoperable Locally Recurrent or Metastatic Anal Cancer (NCT02560298)	ECOG-ACRIN Cancer Research Group	2016-08-23
Surgery in Treating Patients With Early Stage Anal Canal or Perianal Cancer and HIV Infection (NCT02437851)	AIDS Malignancy Consortium	2015-04-01
Prospective Validation Study for the Proprietary Rectal and Anal Cancer Protein Expression Assays (NCT02407561)	Castle Biosciences Incorporated	2015-02-01
Oral Rigosertib for Squamous Cell Carcinoma (NCT01807546)	Traws Pharma, Inc.	2013-03-01
Vectibix for the Treatment of Anal Cancer (NCT01285778)	Grupo Espanol Multidisciplinario del Cancer Digestivo	2010-10-01
A Phase 1 Study in Participants With Advanced Cancer (NCT01115790)	Eli Lilly and Company	2010-02-01

Track Anal Squamous Cell Carcinoma automatically

Every clearance here is in the API, with alerts when new ones post.